Results
19
Gain exposure to companies in the healthcare sector with a strong future outlook and robust financials.
19 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
SECT B | SEK 278.00 | 3.8% | 114.8% | SEK 53.6b | SEK 177.50 | PE119.8x | E21.2% | 0.4% | ||
VIMIAN | SEK 45.45 | 5.6% | 90.6% | SEK 23.7b | SEK 43.99 | PE214.6x | E64.1% | n/a | ||
XVIVO | SEK 506.00 | -1.6% | 84.3% | SEK 15.9b | SEK 549.00 | PE132x | E36.9% | n/a | ||
ARJO B | SEK 45.22 | 3.0% | 6.9% | SEK 12.3b | SEK 52.60 | PE24x | E23.7% | 2.0% | ||
CEVI | SEK 286.00 | 1.8% | 86.2% | SEK 6.8b | SEK 260.50 | PE47x | E24.2% | 0.8% | ||
SUS | SEK 126.50 | 3.9% | -15.8% | SEK 6.5b | SEK 188.17 | PE32.6x | E32.6% | n/a | ||
BACTI B | SEK 57.00 | -8.9% | -12.2% | SEK 2.0b | SEK 80.00 | PS9.5x | E99.7% | n/a | ||
STIL | SEK 214.00 | -2.7% | 102.8% | SEK 1.9b | SEK 270.50 | PE40.2x | E34.4% | 0% | ||
EQL | SEK 53.60 | -2.2% | 100.7% | SEK 1.6b | SEK 45.00 | PE59.3x | E63.4% | n/a | ||
CRAD B | SEK 37.50 | 3.2% | 24.6% | SEK 1.3b | SEK 57.00 | PE23.5x | E33.9% | n/a | ||
PAX | SEK 57.40 | 0.7% | 73.4% | SEK 1.1b | SEK 80.00 | PE38.1x | E50.6% | n/a | ||
SYNT | SEK 27.70 | 0% | -13.4% | SEK 1.2b | SEK 30.00 | PE115.3x | E47.4% | 0% | ||
MNTC | SEK 27.70 | -2.5% | -15.3% | SEK 708.3m | SEK 47.67 | PS2.5x | E73.8% | 0% | ||
INTEG B | SEK 26.80 | -3.2% | -2.7% | SEK 519.8m | SEK 62.50 | PS4.7x | E84.0% | n/a | ||
BOUL | SEK 8.78 | -0.9% | -6.6% | SEK 341.0m | SEK 9.50 | PE16.1x | E36.9% | 0% | ||
ARCOMA | SEK 14.90 | -2.9% | 109.9% | SEK 196.5m | SEK 15.00 | PE15.5x | E16.1% | n/a | ||
IMMNOV BTA | SEK 4.08 | -0.2% | n/a | SEK 193.6m | SEK 81.12 | PS169.1x | E94.9% | n/a | ||
NOSA | SEK 0.60 | -5.5% | -35.1% | SEK 126.1m | n/a | PS10x | E87.4% | n/a | ||
KONT | SEK 2.38 | -8.5% | -6.3% | SEK 76.3m | SEK 5.80 | PE43.6x | E85.4% | n/a |